Quantification of camelid cytokine mRNA expression in PBMCs by microfluidic qPCR technology

dc.contributor.author
Rodon, Jordi
dc.contributor.author
Te, Nigger
dc.contributor.author
Ballester, Maria
dc.contributor.author
Segalés, Joaquim
dc.contributor.author
Serra Gironella, Joan
dc.contributor.author
Bensaid, Albert
dc.contributor.other
Producció Animal
dc.date.accessioned
2025-10-22T11:24:19Z
dc.date.available
2025-10-22T11:24:19Z
dc.date.issued
2023-09-17
dc.identifier.citation
Rodón, Jordi, Nigeer Te, María Ballester, Joaquím Segalés, Júlia Vergara‐Alert, and Albert Bensaïd. 2023. “Quantification of Camelid Cytokine mRNA Expression in PBMCs by Microfluidic qPCR Technology.” Developmental and Comparative Immunology 149: 105061. doi:10.1016/j.dci.2023.105061.
dc.identifier.issn
0145-305X
dc.identifier.uri
https://hdl.handle.net/20.500.12327/2761
dc.description.abstract
Camelids are economically and socially important in several parts of the world and might carry pathogens with epizootic or zoonotic potential. However, biological research in these species is limited due to lack of reagents. Here, we developed RT-qPCR assays to quantify a panel of camelid innate and adaptive immune response genes, which can be monitored in a single run. The assays were validated with PHA, PMA-ionomycin, and Poly I:Cstimulated PBMCs from alpaca, dromedary camel and llama, including normalization by multiple reference genes. Further, comparative gene expression analyses for the different camelid species were performed by a unique microfluidic qPCR assay. Compared to unstimulated controls, PHA and PMA-ionomycin stimulation elicited robust Th1 and Th2 responses in PBMCs from camelid species. Additional activation of type I and type III IFN signalling pathways was described exclusively in PHA-stimulated dromedary lymphocytes, in contrast to those from alpaca and llama. We also found that PolyI:C stimulation induced robust antiviral response genes in alpaca PBMCs. The proposed methodology should be useful for the measurement of immune responses to infection or vaccination in camelid species.
dc.description.sponsorship
This study was performed as part of the Zoonotic Anticipation and Preparedness Initiative (ZAPI project) [Innovative Medicines initiative (IMI) grant 115760] and the Veterinary Biocontained research facility Network (VetBioNet) project (EU Grant Agreement INFRA-2016-1 Nº731014), with assistance and financial support from IMI and the European Commission and contributions from EFPIA partners. J.R. was partially supported by the VetBioNet project. IRTA is supported by CERCA Programme/Generalitat de Catalunya.
dc.format.extent
44
dc.language.iso
eng
dc.publisher
Elsevier
dc.relation.ispartof
Developmental and Comparative Immunology
dc.rights
Attribution-NonCommercial-NoDerivatives 4.0 International
dc.rights.uri
http://creativecommons.org/licenses/by-nc-nd/4.0/
dc.title
Quantification of camelid cytokine mRNA expression in PBMCs by microfluidic qPCR technology
dc.type
info:eu-repo/semantics/article
dc.subject.udc
619
dc.description.version
info:eu-repo/semantics/acceptedVersion
dc.relation.projectID
EC/PF7/115760/EU/Zoonotic Anticipation and Preparedness Initiative/ZAPI
dc.relation.projectID
EC/H2020/731014/EU/Veterinary Biocontained facility Network for excellence in animal infectiology research and experimentation/VetBioNet
dc.identifier.doi
https://doi.org/10.1016/j.dci.2023.105061
dc.rights.accessLevel
info:eu-repo/semantics/openAccess
dc.contributor.group
Genètica i Millora Animal
dc.contributor.group
Sanitat Animal


Files in this item

FilesSizeFormatView

There are no files associated with this item.

This item appears in the following Collection(s)